Transforming clinical apheresis waste into a renewable source of patient-derived CD34+ hematopoietic stem cell biobank for beta-hemoglobinopathy research and therapeutic discovery
Jun Liu, Shin‐Young Park, Hirotomo Nakahara, Yembur Ahmad, Ziyang Shen, Suhayla Sarhan, Stephanie Ferrara, Vanessa Anjurthe, Kristi Georgilas, Sarah Nikiforow, Zankar Desai, Shang‐Chuen Wu, Ryan Philip Jajosky, Sarthak Saha, Nelya Christiansen, , Li Chai
This paper describes a method to recover and biobank CD34+ hematopoietic stem cells from clinical apheresis waste for hemoglobinopathy research, showing comparable yields and viability to peripheral blood samples.
Cytotherapy · Oct 1, 2026Peer-reviewedPharmacology & Toxicology